StockData
Lexicon Pharmaceuticals, Inc. logo

Lexicon Pharmaceuticals, Inc. (LXRX) stock

LXRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 5/3082% above fair value
$1.72−0.06 (-3.37%)

Close on Nov 18, 2026Market cap $765.32MP/E –Yield –

Lexicon Pharmaceuticals revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Lexicon Pharmaceuticals's revenue for the twelve months ending Jun 30, 2026 was $41.47M, down 29.0% year over year. For fiscal 2025 it was $49.80M, up 60.2% from the year before. Over ten years it grew -9.1% a year on average. The highest annual figure on record is $322.07M in fiscal 2019.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$49.80M+60.2%
FY2024Dec 31, 2024$31.08M+2481.5%
FY2023Dec 31, 2023$1.20M+766.2%
FY2022Dec 31, 2022$139.00K-53.4%
FY2021Dec 31, 2021$298.00K-98.8%
FY2020Dec 31, 2020$24.00M-92.5%
FY2019Dec 31, 2019$322.07M+409.5%
FY2018Dec 31, 2018$63.21M-31.1%
FY2017Dec 31, 2017$91.69M+15.7%
FY2016Dec 31, 2016$79.26M-39.0%
FY2015Dec 31, 2015$130.01M+468.9%
FY2014Dec 31, 2014$22.85M+928.5%
FY2013Dec 31, 2013$2.22M+104.0%
FY2012Dec 31, 2012$1.09M-41.1%
FY2011Dec 31, 2011$1.85M-62.3%
FY2010Dec 31, 2010$4.91M-54.1%
FY2009Dec 31, 2009$10.70M–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$692.00K-97.6%
Q1 FY2026Mar 31, 2026$21.10M+1572.1%
Q4 FY2025Dec 31, 2025$5.49M-79.3%
Q3 FY2025Sep 30, 2025$14.18M+710.4%
Q2 FY2025Jun 30, 2025$28.87M+1652.6%
Q1 FY2025Mar 31, 2025$1.26M+11.7%
Q4 FY2024Dec 31, 2024$26.55M+3682.6%
Q3 FY2024Sep 30, 2024$1.75M+980.2%
Q2 FY2024Jun 30, 2024$1.65M+419.6%
Q1 FY2024Mar 31, 2024$1.13M+4608.3%
Q4 FY2023Dec 31, 2023$702.00K+2407.1%
Q3 FY2023Sep 30, 2023$162.00K+315.4%
Q2 FY2023Jun 30, 2023$317.00K+805.7%
Q1 FY2023Mar 31, 2023$24.00K+71.4%
Q4 FY2022Dec 31, 2022$28.00K+21.7%
Q3 FY2022Sep 30, 2022$39.00K-83.3%
Q2 FY2022Jun 30, 2022$35.00K+29.6%
Q4 FY2021Dec 31, 2021$14.00K-93.0%
Q3 FY2021Sep 30, 2021$23.00K-99.7%
Q2 FY2021Jun 30, 2021$234.00K-97.4%
Q1 FY2021Mar 31, 2021$27.00K-99.7%
Q4 FY2020Dec 31, 2020$199.00K-97.7%
Q3 FY2020Sep 30, 2020$6.63M-97.7%
Q2 FY2020Jun 30, 2020$9.16M-5.4%
Q1 FY2020Mar 31, 2020$8.00M-13.2%
Q4 FY2019Dec 31, 2019$8.73M-48.9%
Q3 FY2019Sep 30, 2019$294.45M+4126.9%
Q2 FY2019Jun 30, 2019$9.68M-29.8%
Q1 FY2019Mar 31, 2019$9.22M-63.7%
Q4 FY2018Dec 31, 2018$17.07M-49.7%
Q3 FY2018Sep 30, 2018$6.97M-74.8%
Q2 FY2018Jun 30, 2018$13.80M+14.2%
Q1 FY2018Mar 31, 2018$25.37M+41.3%
Q4 FY2017Dec 31, 2017$33.97M+47.4%
Q3 FY2017Sep 30, 2017$27.67M-0.2%
Q2 FY2017Jun 30, 2017$12.09M–
Q1 FY2017Mar 31, 2017$17.96M–
Q4 FY2016Dec 31, 2016$23.04M–
Q3 FY2016Sep 30, 2016$27.72M–

More Lexicon Pharmaceuticals figures

See a number that looks wrong?